Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer's disease
Cholinesterase inhibitor plays an important role in the treatment of patients with Alzheimer's disease (AD). Herein, we report the medicinal chemistry efforts leading to a new series of 1,3-dimethylbenzimidazolinone derivatives. Among the synthesised compounds, 15b and 15j showed submicromolar...
Saved in:
Main Authors: | Jun Mo (Author), Tingkai Chen (Author), Hongyu Yang (Author), Yan Guo (Author), Qi Li (Author), Yuting Qiao (Author), Hongzhi Lin (Author), Feng Feng (Author), Wenyuan Liu (Author), Yao Chen (Author), Zongliang Liu (Author), Haopeng Sun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease
by: Jie Zhu, et al.
Published: (2018) -
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease
by: Yao Chen, et al.
Published: (2018) -
Design, synthesis and evaluation of OA-tacrine hybrids as cholinesterase inhibitors with low neurotoxicity and hepatotoxicity against Alzheimer's disease
by: Huali Yang, et al.
Published: (2023) -
Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer's Disease
by: Ignazio Schino, et al.
Published: (2022) -
Degradation of proteins by PROTACs and other strategies
by: Yang Wang, et al.
Published: (2020)